Hemostatic agents for prehospital hemorrhage control: a narrative review
- PMID: 32209132
- PMCID: PMC7093954
- DOI: 10.1186/s40779-020-00241-z
Hemostatic agents for prehospital hemorrhage control: a narrative review
Abstract
Hemorrhage is the leading cause of preventable death in combat trauma and the secondary cause of death in civilian trauma. A significant number of deaths due to hemorrhage occur before and in the first hour after hospital arrival. A literature search was performed through PubMed, Scopus, and Institute of Scientific Information databases for English language articles using terms relating to hemostatic agents, prehospital, battlefield or combat dressings, and prehospital hemostatic resuscitation, followed by cross-reference searching. Abstracts were screened to determine relevance and whether appropriate further review of the original articles was warranted. Based on these findings, this paper provides a review of a variety of hemostatic agents ranging from clinically approved products for human use to newly developed concepts with great potential for use in prehospital settings. These hemostatic agents can be administered either systemically or locally to stop bleeding through different mechanisms of action. Comparisons of current hemostatic products and further directions for prehospital hemorrhage control are also discussed.
Keywords: Hemorrhage control; Hemostatic agent; Trauma.
Conflict of interest statement
The author declares that he has no competing interests.
Similar articles
-
Topical hemostatic agents and dressings in the prehospital setting.Curr Opin Anaesthesiol. 2015 Apr;28(2):210-6. doi: 10.1097/ACO.0000000000000166. Curr Opin Anaesthesiol. 2015. PMID: 25674988 Review.
-
Tranexamic acid as part of remote damage-control resuscitation in the prehospital setting: A critical appraisal of the medical literature and available alternatives.J Trauma Acute Care Surg. 2015 Jun;78(6 Suppl 1):S70-5. doi: 10.1097/TA.0000000000000640. J Trauma Acute Care Surg. 2015. PMID: 26002268 Review.
-
Coagulation factor concentrate-based therapy for remote damage control resuscitation (RDCR): a reasonable alternative?Transfusion. 2016 Apr;56 Suppl 2:S157-65. doi: 10.1111/trf.13526. Transfusion. 2016. PMID: 27100752
-
Ruggedized Self-Propelling Hemostatic Gauze Delivers Low Dose of Thrombin and Systemic Tranexamic Acid and Achieves High Survival in Swine With Junctional Hemorrhage.Mil Med. 2023 Nov 8;188(Suppl 6):280-287. doi: 10.1093/milmed/usad110. Mil Med. 2023. PMID: 37948225
-
The cellular basis of traumatic bleeding.Mil Med. 2004 Dec;169(12 Suppl):5-7, 4. doi: 10.7205/milmed.169.12s.5. Mil Med. 2004. PMID: 15651432 Review.
Cited by
-
A polymer-based systemic hemostatic agent.Sci Adv. 2020 Jul 31;6(31):eaba0588. doi: 10.1126/sciadv.aba0588. eCollection 2020 Jul. Sci Adv. 2020. PMID: 32775633 Free PMC article.
-
Engineering injectable bone/bioadhesive grafts delivery system with self-healing properties for bone regeneration.Bioact Mater. 2025 Aug 11;54:47-70. doi: 10.1016/j.bioactmat.2025.07.049. eCollection 2025 Dec. Bioact Mater. 2025. PMID: 40831708 Free PMC article.
-
Dried Plasma for Major Trauma: Past, Present, and Future.Life (Basel). 2024 May 10;14(5):619. doi: 10.3390/life14050619. Life (Basel). 2024. PMID: 38792640 Free PMC article. Review.
-
Contemporary management of traumatic cardiac arrest and peri-arrest states: a narrative review.J Anesth Analg Crit Care. 2024 Sep 26;4(1):66. doi: 10.1186/s44158-024-00197-9. J Anesth Analg Crit Care. 2024. PMID: 39327636 Free PMC article. Review.
-
Silk Fibroin-Based Biomaterials for Hemostatic Applications.Biomolecules. 2022 Apr 30;12(5):660. doi: 10.3390/biom12050660. Biomolecules. 2022. PMID: 35625588 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical